Cara Therapeutics Inc (NASDAQ: CARA) Q1 2023 earnings call dated May. 15, 2023 Corporate Participants: Matthew Murphy -- Manager of Investor Relations Christopher Posner -- Chief
Cara Therapeutics Inc.
-(CARA)
XLON:CARA, XNAS:CARA
Cara Therapeutics Inc (CARA) Q4 2022 Earnings Call Transcript
Cara Therapeutics Inc (NASDAQ:CARA) Q4 2022 Earnings Call dated Mar. 06, 2023. Corporate Participants: Chris Posner -- President and Chief Executive Officer Ryan Maynard -- Chief
Cara Therapeutics Inc (CARA) Q3 2022 Earnings Call Transcript
Cara Therapeutics Inc (NASDAQ:CARA) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Matthew Murphy -- Investor Relations Manager Christopher Posner -- Chief Executive Officer,
Cara Therapeutics , Inc. (CARA) Q2 2022 Earnings Call Transcript
Cara Therapeutics , Inc. (NASDAQ: CARA) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Iris Francesconi -- Chief Strategy Officer and Head
Cara Therapeutics Inc. (CARA) Q1 2022 Earnings Call Transcript
Cara Therapeutics Inc. (NASDAQ: CARA) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Iris Francesconi -- Interim Head of Investor Relations Christopher
Cara Therapeutics, Inc. (CARA) Q3 2021 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ: CARA) Q3 2021 earnings call dated Nov. 08, 2021 Corporate Participants: Will Gramig -- Senior Analyst Derek Chalmers -- Chief Executive Officer,
Cara Therapeutics, Inc. CARA) Q2 2021 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ: CARA) Q2 2021 earnings call dated Aug. 09, 2021 Corporate Participants: Cole Herlitz-Ferguson -- Investor Relations Derek Chalmers -- Chief Executive Officer,
Cara Therapeutics Inc (CARA) Q1 2021 Earnings Call Transcript
Cara Therapeutics Inc (NASDAQ:CARA) Q1 2021 earnings call dated May. 10, 2021. Corporate Participants: Jack Hildick-Smith -- Investor Relations Derek Chalmers -- Chief Executive Officer, President,
Cara Therapeutics Inc. (NASDAQ: CARA) Q1 2020 Earnings Call Transcript
Cara Therapeutics Inc. (CARA) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Jack Hildick-Smith -- Investor Relations Derek Chalmers -- Chief Executive Officer, President,
Cara Therapeutics Inc. (NASDAQ: CARA) Q4 2019 Earnings Call Transcript
Cara Therapeutics Inc (NASDAQ: CARA) Q4 2019 Earnings Conference Call Final Transcript Corporate participants: Jack Hildick-Smith -- Investor Relations Derek Chalmers -- President, Director and Chief Executive
Cara Therapeutics’ (CARA) loss expands in Q3 on higher costs
Cara Therapeutics' (NASDAQ: CARA) loss widened in the third quarter of 2019, hurt by higher expenses. Cara Therapeutics posted a loss of
Cara Therapeutics Q1 loss widens but beats estimates
Cara Therapeutics Inc. (NASDAQ: CARA) reported a wider loss in the first quarter of 2019 due to higher costs and expenses. The bottom
Earnings: Trevena slips on wider-than-expected Q4 loss
Trevena Inc (TRVN) Wednesday reported fourth-quarter losses that were wider than analysts’ estimates, sending its shares down 5.4% during pre-market trading. Helped
Cara Therapeutics stock surges after reporting Q4 earnings results
Cara Therapuetics (CARA) reports a loss of $20.7 million or $0.52 per share on revenue of $5.5 million for the fourth quarter
Earnings Preview Q4: Cara Therapeutics’ success in 2019 will depend on Korsuva trial outcomes
Cara Therapeutics (CARA) is scheduled to report its fourth quarter and full-year 2018 financial results on Tuesday, March 12, after the regular